Several Chinese herbal products may contain toxic aristolochic acid

Wooltorton, Eric
August 2004
CMAJ: Canadian Medical Association Journal;8/31/2004, Vol. 171 Issue 5, p449
Academic Journal
Provides information on aristolochic acid, a naturally occurring herbal toxin that can cause cancer and end-stage kidney failure. Precautions issued by the Health Canada concerning several Chinese herbal products containing aristolochic acid; Discussion on the toxicity of aristolochic acid.


Related Articles

  • Potentially harmful drug interaction with St.John's wort and prescription drugs. Springuel, Pascale // CMAJ: Canadian Medical Association Journal;7/11/2000, Vol. 163 Issue 1, p85 

    Offers information provided by Health Canada regarding potentially harmful drug reactions and interactions. Dangers of using St. John's wort and prescription drugs; Suspected reactions caused by the drug Olanzapine; Cardiac risks associated with Sildenafil.

  • Health Canada warns about adulteration of herbal medicines.  // Reactions Weekly;11/11/2006, Issue 1127, p3 

    The article reveals that Health Canada has advised consumers not to use herbal medicines such as Zimaxx and Actra-Rx as they could pose a serious health risk because of adulteration with ingredients that should only be used under medical supervision. The agency has warned that the use of such...

  • Sleeping with Sleepees can become a habit.  // Reactions Weekly;3/3/2007, Issue 1141, p4 

    The article reports that Health Canada has warned against using the herbal sleep aid Sleepees because it was found to contain undeclared estazolam, a habit forming drug. To those who have used the drug, discontinuing its use may cause withdrawal symptoms and so Health Canada has advised...

  • Health Canada requests clarity in botulinum toxin naming.  // Reactions Weekly;2/2/2013, Issue 1437, p3 

    The article reports that Health Canada has asked the manufacturers of botulinum toxin products to revise their labelling to reflect that each product has its own potency and is not interchangeable with other botulinum toxin products.

  • Pharmacovigilance & Regulatory News.  // Reactions Weekly;3/1/2008, Issue 1191, p2 

    The article reports on the safety review being conducted by Health Canada on distant toxin spread associated with botulinum A. The agency said the review started following adverse events related to distant toxin spread from botulinum toxin products were reported. Health Canada noted that there...

  • The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.  // CMAJ: Canadian Medical Association Journal;1998 Supplement 3, Vol. 158, pS1 

    An introduction is presented which discusses various articles within the issue on topics including a list of members of the Health Canada's Steering Committee on clinical practice guidelines, evidences supporting each guideline, and guidelines on the treatment of breast cancer.

  • Pharmacovigilance & Regulatory News.  // Reactions Weekly;8/13/2011, Issue 1364, p3 

    This article reports on the move of Health Canada to warn medical personnel and patients of the risks of male breast cancer associated with the use of finasteride.

  • Aortic thrombosis after cisplatin treatment.  // Reactions Weekly;Aug2014, Vol. 1513 Issue 1, p2 

    The article informs on the cases of aortic thrombosis found in cancer patients after the initiation of cisplatin treatment which have been reported to government medicare department of Canada, Health Canada.

  • Detox. Starbuck, Jamison // Better Nutrition;Mar2001, Vol. 63 Issue 3, p53 

    Focuses on the use of herbs in reducing the health effects of environmental toxins. Benefits of dandelion in promoting good liver function; Potency of turmeric in decreasing production of inflammation inducing compounds; Recommendations on the use of green tea to increase detoxification mechanism.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics